{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-046010","form_type":"8-K","ticker":"CHRN","cik":"0001549084","company_name":"EKSO BIONICS HOLDINGS, INC.","filed_at":"2026-10-06T21:20:39+00:00","discovered_at":"2026-10-06T21:22:00.217955+00:00","generated_at":"2026-10-12T16:07:22.483936+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"ChronoScale director Scott Davis resigns after Ekso sale; gets $709,500 and 51,626 RSUs","bullets":["Scott Davis, Ekso Bionics CEO and ChronoScale board member, resigned from the board effective October 3, 2026, with no disagreements cited; the Ekso sale closed September 30, 2026.","Davis received 51,626 fully vested restricted stock units granted October 2, 2026, plus a $709,500 lump-sum cash payment payable within 30 days under a Release Agreement.","The Release Agreement includes a general release of claims and stands in lieu of any payment under the Nov. 5, 2025 Change in Control and Severance Agreement; the Phantom RSU Agreement is unchanged.","ChronoScale common stock trades on the Nasdaq Capital Market under CHRN; CFO Jerome Wong signed the report dated October 6, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-046010","json":"https://secwatch.observer/filing/0001493152-26-046010.json","markdown":"https://secwatch.observer/filing/0001493152-26-046010.md","text":"https://secwatch.observer/filing/0001493152-26-046010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1549084/000149315226046010/0001493152-26-046010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1549084/000149315226046010/form8-k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T16:07:22.483936+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"44137d47a3","claim":"Scott Davis resigned as Member of the Board of Directors at EKSO BIONICS HOLDINGS, INC..","evidence_excerpt":"Scott Davis, a member of the Board of Directors of the Company (the “Board”) and Chief Executive Officer (“CEO”) of Ekso, resigned from his position as a member of the Board, effective as of October 3, 2026. There were no disagreements between the Company and Mr. Davis that led to his decision to resign.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1549084/000149315226046010/0001493152-26-046010-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Member of the Board of Directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}